Related Experiment Video

Updated: Dec 22, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K

Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development

Kevin W Graepel1, Sonali Kochhar2,3, Ellen W Clayton4,5,6

  • 1Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

The Journal of Infectious Diseases
|May 5, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.3K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.8K

Related Experiment Videos

Last Updated: Dec 22, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.3K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.8K

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

143
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
143

Articles linked to this work by shared authors, journal, and citation graph.

Navigating data sharing in research.

American journal of human genetics·2026

Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology.

Journal of global health·2026

Identifying and supporting trafficked individuals: provider and community organization perspectives on existing sociotechnical approaches.

Journal of the American Medical Informatics Association : JAMIA·2025

Ethical sourcing in the context of health data supply chain management: a value sensitive design approach.

JAMIA open·2025

Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers.

Vaccine·2025

Computational strategic recruitment for representation and coverage studied in the All of Us Research Program.

NPJ digital medicine·2025

The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.

The Journal of infectious diseases·2026

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.

The Journal of infectious diseases·2026

Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum: comparison of 2014-2015 and 2022-2024 surveys in northern Uganda.

The Journal of infectious diseases·2026

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species.

The Journal of infectious diseases·2026

Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants.

The Journal of infectious diseases·2026

Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.

The Journal of infectious diseases·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us